Novonesis (Novozymes) B
NSISBC
Rank in Stocks
#1160
Established in January 2024 through the amalgamation of Novozymes A/S and Chr.... Established in January 2024 through the amalgamation of Novozymes A/S and Chr. Hansen, Novonesis now stands as a prominent global leader in biosolutions. The firm's activities encompass the worldwide development and commercialization of industrial enzymes, diverse microorganisms, and vital biopharmaceutical ingredients. Distinctively, its Class B shares are listed independently and actively traded on various European exchanges.
Share Price
$70.10
Last synced: 2026-10-21
Market Cap
$19.48B
Change (1 day)
-4.64%
Change (1 year)
10.57%
Country
DK
Trade Novonesis (Novozymes) B (NSISBC)
Category
Basic Materials
Stock price history for Novonesis (Novozymes) B (NSISBC)
Highest end of day price: $69.71 on 2026-10-01
Lowest end of day price: $58.74 on 2024-03-01
Lowest end of day price: $58.74 on 2024-03-01
Stock price history of Novonesis (Novozymes) B from 2024 to 2026
Annual Stock Price Performance
| Year | Performance |
|---|---|
| 2026 (TTM) | 1.84% |
| 2025 | 7.42% |
| 2024 | 0.00% |
Stock price for similar companies or competitors
| Company | Stock price | Change 1y% | Country |
|---|---|---|---|
| $498.80 | 10.86% |
GB
|
|
| $194.80 | 7.03% |
FR
|
|
| $337.21 | 1.02% |
US
|
|
| $287.77 | 4.26% |
US
|
|
| $302.56 | 19.52% |
US
|
